Drag

Antifungal Topical + Oral

Brand Logo
Brand Logo
Brand Logo
Brand Logo
Brand Logo
Brand Logo
Brand Logo
Brand Logo
Brand Logo
Brand Logo
Brand Logo
Brand Logo
Brand Logo
Brand Logo

The antifungal topical and oral category includes preparations for fungal infections of skin, nails and body folds. Topical antifungals are commonly applied once or twice daily for several weeks to clear localized fungal skin infections such as tinea and candidiasis. Oral antifungals are reserved for extensive, recurrent, or nail disease and require careful monitoring. 

Key products

1. Lulizol Cream/Lotion – Topical antifungal cream and lotion used for dermatophyte infections and other physician-diagnosed mycoses. 

2. Eberfine-M Cream, Episert Cream, Canrolfin Cream – Combination or single-agent creams for fungal infections with or without significant inflammation. 

3. Kenz Soap/Lotion/Cream/Tablet – Comprehensive antifungal range with cleansing, topical and systemic options. 

4. Zycozol Cream – Topical antifungal cream for affected skin areas. 

5. Niofine Tablet/Dusting Powder, Niofine Forte Tablet – Oral antifungal tablets and dusting powder used in stepwise escalation according to severity. 

6. Onitraz Capsule, Onitraz-Forte Capsule, Zoritraz Capsule, Zoritraz-Forte Capsule, Onitraz SB 130/65 Capsule – Itraconazole-class systemic antifungals used under strict medical supervision. 

Key active ingredients 

This category mainly comprises azole and allylamine antifungals in topical and oral forms, often combined with anti-inflammatory or antibacterial agents in select products. Treatment duration and dosing are determined by site, organism, host factors, and prior treatment history, making adherence to medical advice crucial. 

FAQ

Topicals are typically used for localized, superficial infections, while oral agents are reserved for extensive, recurrent, or nail and hair involvement. Dermatologists decide escalation based on clinical pattern, prior response, and patient comorbidities.

Appropriate indication, correct dosing, and adequate but finite duration are central. Clinicians monitor liver function where indicated, review drug–drug interactions, and avoid empirical long‑term courses without mycologic or clinical justification.

Education on hygiene, footwear, and environmental decontamination is crucial. Many clinicians implement short prophylactic or maintenance regimens in high‑risk patients, coupled with regular follow‑up to detect recurrence early.